Weiss Multi-Strategy Advisers’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-90,000
| Closed | -$153K | – | 205 |
|
|
2023
Q4 | $153K | Sell |
90,000
-38,559
| -30% | -$65.6K | ﹤0.01% | 459 |
|
|
2023
Q3 | $132K | Sell |
128,559
-15,133
| -11% | -$15.5K | ﹤0.01% | 493 |
|
|
2023
Q2 | $167K | Sell |
143,692
-14,834
| -9% | -$17.2K | ﹤0.01% | 561 |
|
|
2023
Q1 | $239K | Sell |
158,526
-2,779
| -2% | -$4.19K | 0.01% | 543 |
|
|
2022
Q4 | $403K | Sell |
161,305
-3,695
| -2% | -$9.23K | 0.01% | 509 |
|
|
2022
Q3 | $696K | Buy |
165,000
+129,304
| +362% | +$545K | 0.02% | 503 |
|
|
2022
Q2 | $100K | Sell |
35,696
-7,132
| -17% | -$20K | ﹤0.01% | 617 |
|
|
2022
Q1 | $245K | Buy |
42,828
+328
| +0.8% | +$1.88K | 0.01% | 594 |
|
|
2021
Q4 | $388K | Buy |
42,500
+21,757
| +105% | +$199K | 0.01% | 545 |
|
|
2021
Q3 | $222K | Buy |
20,743
+454
| +2% | +$4.86K | ﹤0.01% | 596 |
|
|
2021
Q2 | $315K | Buy |
20,289
+984
| +5% | +$15.3K | 0.01% | 568 |
|
|
2021
Q1 | $313K | Sell |
19,305
-790
| -4% | -$12.8K | 0.01% | 567 |
|
|
2020
Q4 | $425K | Sell |
20,095
-5,121
| -20% | -$108K | 0.01% | 545 |
|
|
2020
Q3 | $374K | Sell |
25,216
-4,284
| -15% | -$63.5K | 0.01% | 482 |
|
|
2020
Q2 | $434K | Sell |
29,500
-1,390
| -4% | -$20.4K | 0.01% | 456 |
|
|
2020
Q1 | $363K | Sell |
30,890
-1,110
| -3% | -$13K | 0.01% | 350 |
|
|
2019
Q4 | $752K | Buy |
32,000
+22,000
| +220% | +$517K | 0.01% | 439 |
|
|
2019
Q3 | $185K | Hold |
10,000
| – | – | ﹤0.01% | 440 |
|
|
2019
Q2 | $186K | Buy |
+10,000
| New | +$186K | ﹤0.01% | 387 |
|